Immunotherapeutic Approaches to Alzheimer's Disease

Science

Volumn 302, Issue 5646, 2003, Pages 834-838

  Monsonego, Alon ^a   Weiner, Howard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; HEALTH; IMMUNOLOGY; NEUROLOGY;

ALZHEIMER DISEASE;

DISEASES;

AMYLOID BETA PROTEIN; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PRION PROTEIN;

ALZHEIMER DISEASE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ASTROCYTE; CELL ACTIVATION; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MICROGLIA; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ALZHEIMER DISEASE; ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODY FORMATION; ANTIGEN-PRESENTING CELLS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; HUMANS; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; IMMUNIZATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MICROGLIA; NITRIC OXIDE; T-LYMPHOCYTES;

ANIMALIA;

EID: 0242268945     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1088469     Document Type: Review

References (73)

1. Z. Zhang et al., Nature Cell. Biol. 2, 463 (2000).
2. W. T. Kimberly et al., Biochemistry 42, 137 (2003).
3. D. J. Selkoe, Physiol. Rev. 81, 741 (2001).
4. E. G. McGeer, P. L. McGeer, Exp. Gerontol. 33, 371 (1998).
5. N. R. Cooper, R. N. Kalaria, P. L. McGeer, J. Rogers, Neurobiol Aging 21, 451 (2000).
6. H. Akiyama et al., Neurobiol. Aging 21, 383 (2000).
7. D. L. Price, S. S. Sisodia, Annu. Rev. Neurosci. 21, 479 (1998).
8. J. El Khoury et al., Nature 382, 716 (1996).
9. J. Husemann, J. D. Loike, T. Kodama, S. C. Silverstein, J. Neuroimmunol. 114, 142 (2001).
10. L. F. Lue et al., Glia 35, 72 (2001).
11. J. Haas, B. Storch-Hagenlocher, A. Biessmann, B. Wildemann, Neurosci. Lett. 322, 121 (2002).
12. M. T. Heneka et al., J. Neurosci. 22, 2434 (2002).
13. T. Wyss-Coray, L. Mucke, Neuron 35, 419 (2002).
14. J. L. Eriksen et al., J. Clin. Invest. 112, 440 (2003).
15. W. F. Hickey, K. Vass, H. Lassmann, J. Neuropathol. Exp. Neurol. 51, 246 (1992).
16. K. Williams, X. Alvarez, A. A. Lackner, Glia 36, 156 (2001).
17. W. F. Hickey, H. Kimura, Science 239, 290 (1988).
18. L. Santambrogio et al., Proc. Natl. Acad. Sci. U.S.A. 98, 6295 (2001).
19. H. G. Fischer, G. Reichmann, J. Immunol. 166, 2717 (2001).
20. B. Becher, A. Prat, J. P. Antel, Glia 29, 293 (2000).
21. R. Seguin et al., Glia 42, 36 (2003).
22. A. Monsonego, H. L. Weiner, unpublished data.
23. E. Tarkowski, A. Wallin, B. Regland, K. Blennow, A. Tarkowski, Acta. Neurol. Scand. 103, 166 (2001).
24. F. Aloisi, Glia 36, 165 (2001).
25. L. M. Phillips, L. A. Lampson, J. Neuroimmunol. 96, 218 (1999).
26. A. Monsonego, J. Imitola, Z. Zota, T. Oida, H. L. Weiner, J. Immunol. 171(5), 2216 (2003).
27. C. Bogdan, Nature Immunol. 2, 907 (2001).
28. R. C. van der Veen, Int. Immunopharmacol. 1, 1491 (2001).
29. G. Gammon, E. Sercarz, Nature 342, 183 (1989).
30. D. A. Peterson, R. J. DiPaolo, O. Kanagawa, E. R. Unanue, Immunity 11, 453 (1999).
31. C. A. Janeway Jr., Curr. Biol. 9, R342 (1999).
32. I. R. Cohen, Immunol. Today 13, 441 (1992).
33. A. Kitani, K. Chua, K. Nakamura, W. Strober, J. Immunol. 165, 691 (2000).
34. I. R. Cohen, J. Autoimmunol. 16, 337 (2001).
35. M. Schwartz, J. Kipnis, Trends Immunol. 23, 530 (2002).
36. I. Apostolou, A. Sarukhan, L. Klein, H. von Boehmer, Nature Immunol. 3, 756 (2002).
37. K. Kawahata et al., J. Immunol. 168, 4399 (2002).
38. C. Scheinecker, R. McHugh, E. M. Shevach, R. N. Germain, J. Exp. Med. 196, 1079 (2002).
39. H. Wekerle, Intervirology 35, 95 (1993).
40. W. F. Hickey, Glia 36, 118 (2001).
41. A. L. Ford, E. Foulcher, F. A. Lemckert, J. D. Sedgwick, J. Exp. Med. 184, 1737 (1996).
42. J. Bauer et al., Am. J. Pathol. 153, 715 (Sep, 1998).
43. G. Moalem, A. Nonsonego, Y. Shani, I. R. Cohen, M. Schwartz, FASEB J. 13, 1207 (1999).
44. A. Monsonego et al., J. Clin. Invest. 112, 415 (2003).
45. D. Frenkel, O. Katz, B. Solomon, Proc. Natl. Acad. Sci. U.S.A. 97, 11455 (2000).
46. A. Monsonego, R. Maron, V. Zota, D. J. Selkoe, H. L. Weiner, Proc. Natl. Acad. Sci. U.S.A. 98, 10273 (2001).
47. E. T. Spooner, R. V. Desai, C. Mori, J. F. Leverone, C. A. Lemere, Vaccine 21, 290 (2002).
48. J. McLaurin et al., Nature Med. 8, 1263 (2002).
49. G. Moalem et al., Nature Med. 5, 49 (1999).
50. E. Hauben et al., Lancet 355, 286 (2000).
51. H. Hammarberg et al., J. Neurosci. 20, S283 (2000).
52. J. Kipnis et al., J. Neurosci. 21, 4564 (2001).
53. K. J. Becker et al., Proc. Natl. Acad. Sci. U.S.A. 94, 10873 (1997).
54. E. van Exel et al., Stroke 33, 1135 (2002).
55. D. Schenk et al., Nature 400, 173 (1999).
56. D. Morgan et al., Nature 408, 982 (2000).
57. C. Janus et al., Nature 408, 979 (2000).
58. H. L. Weiner et al., Ann. Neurol. 48, 567 (2000).
59. C. A. Lemere et al., Ann. N. Y. Acad. Sci. 920, 328 (2000).
60. J. C. Dodart et al., Nature Neurosci. 5, 452 (2002).
61. F. Bard et al., Nature Med. 6, 916 (2000).
62. R. B. DeMattos et al., Proc. Natl. Acad. Sci. U S A 98, 8850 (2001).
63. M. Pfeifer et al., Science 298, 1379. (2002).
64. T. Wyss-Coray et al., Nature Med. 7, 612 (2001).
65. T. Wyss-Coray et al., Nature Med. 9, 453 (2003).
66. J. A. Nicoll et al., Nature Med. 9, 448 (2003).
67. J. M. Orgogozo et al., Neurology 61, 46 (2003).
68. C. Hock et al., Neuron 38, 547 (2003).
69. H. J. Kim et al., Clin. Immunol. 104, 105 (2002).
70. E. Yoles et al., J. Neurosci. 21, 3740 (2001).
71. D. Frenkel et al., Clin. Immunol. suppl. 1, abs. 411 (2002).
72. M. J. During et al., Science 287, 1453 (2000).
73. A. R. White et al., Nature 422, 80 (2003).